arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Astrana Health, Inc.

ASTH
$38.99 ▼ -0.68 (-1.71%) at close
Industrials ·Services-Management Consulting Services ·USServices-Management Consulting Services
55 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
48
Health
Weak
Bearish
auto_awesome

Analytical Summary

Astrana Health, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $1.9B
Dividend Yield —
Revenue Growth 48.5% ↘
Op. Margin 3.5% ↗
ROIC 1.4% ↗
FCF / Share $0.59 ↘
Trailing P/E 97.5x
Price / Book 2.3x
FCF Yield 1.5%
Debt / Equity 1.06
info Valuation on last close. End-of-day price, Nov 5, 2026.

55-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$972.52M
↑ +48.5% —
Net Income Profit after all expenses
$19.74M
↑ +109.5% —
Operating Margin Operating profit as % of sales
3.5%
↑ +19.4% 35th
FCF / Share Free cash flow per share
$0.59
↓ -55.2% —
Long-Term Debt Long-term obligations
$882.65M
↓ -9.9% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability ↓
35
Returns ↓
49
Financial Health →
40
Cash Quality ↑
95

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 14 years · 55 quarters